Reactivation and shedding of cytomegalovirus in astronauts during spaceflight.

The reactivation of cytomegalovirus (CMV) in 71 astronauts was investigated, using polymerase chain reaction. A significantly greater (P<.0001) shedding frequency was found in urine samples from astronauts before spaceflight (10.6%) than in urine from the healthy control subject group (1.2%). Two of 4 astronauts studied during spaceflight shed CMV in urine. A significant increase (P<.0001) in CMV antibody titer, compared with baseline values, was also found 10 days before spaceflight. CMV antibody titer was further increased (P<.001) 3 days after landing, compared with 10 days before the mission. Significant increases in stress hormones were also found after landing. These results demonstrate that CMV reactivation occurred in astronauts before spaceflight and indicate that CMV may further reactivate during spaceflight.

[1]  Daniel L. Feeback,et al.  Stress-Induced Reactivation of Epstein-Barr Virus in Astronauts , 2000, Neuroimmunomodulation.

[2]  D. Lugg,et al.  Epstein‐Barr virus reactivation associated with diminished cell‐mediated immunity in Antarctic expeditioners , 2000, Journal of medical virology.

[3]  K. Matalka,et al.  Academic Stress—Influence on Epstein-Barr Virus and Cytomegalovirus Reactivation, Cortisol, and Prolactin , 2000 .

[4]  D. Pierson,et al.  Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. , 1999, Aviation, space, and environmental medicine.

[5]  D. Lugg,et al.  Antarctic isolation: Immune and viral studies , 1997, Immunology and cell biology.

[6]  G Sonnenfeld,et al.  Changes in the immune system during and after spaceflight. , 1997, Advances in space biology and medicine.

[7]  T P Stein,et al.  Excretion of IL-6 by astronauts during spaceflight. , 1994, The American journal of physiology.

[8]  Diane Lambert,et al.  Zero-inflacted Poisson regression, with an application to defects in manufacturing , 1992 .

[9]  S. Spector,et al.  Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages , 1991, Journal of virology.

[10]  K. Kaushansky,et al.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Rice,et al.  Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Sato,et al.  Enhanced replication of human cytomegalovirus in human fibroblasts treated with dexamethasone. , 1984, The Journal of general virology.

[13]  S. Kamiya,et al.  Dexamethasone enhances human cytomegalovirus replication in human epithelial cell cultures. , 1984, Virology.

[14]  M. Hirsch,et al.  Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. , 1981, The Journal of infectious diseases.

[15]  W. Henle,et al.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. , 1975, The Journal of infectious diseases.